• Skip to primary navigation
  • Skip to main content
  • Skip to footer
NICO CorporationSecondary logo

NICO Corporation

Dedicated to revolutionizing minimally invasive neurosurgery

  • Home
  • Patients
  • Professionals
    • Our Capabilities
    • Our Integrated System
    • Our Surgical Focus
    • Our Impact
    • Published Data
    • Investigator Initiated Study Program
      • IIS Program Overview
      • IIS Areas of Interest (AOIs)
    • Donation Request
    • Global Distribution
    • NICO Technologies for Animal Health
    • Neurosurgeon Education
  • Company
    • Our Mission
    • Our Leadership Team
    • News & Events
    • Careers
  • LinkedIn
  • Twitter
  • YouTube

Multi-Center Intracerebral Hemorrhage Pilot Study Yields Statistically Significant Data for Early Intervention

Home » Multi-Center Intracerebral Hemorrhage Pilot Study Yields Statistically Significant Data for Early Intervention

February 12, 2015 by admin

International Stroke Conference presentation highlights clinical results using BrainPath® technology for atraumatic access to emergent brain abnormalities

Nashville, TN — On Thursday, February 12, 2015, the results of a 35 patient, multi-center pilot study spanning a two-year period will be presented to the International Stroke Conference. “The Safety and Efficacy of Image Guided Trans-Sulcal Radial Corridors for Hematoma Evacuation: A Multi-Center Study” will be presented by Dr. Mohamed Labib, a neurosurgeon at the University of Ottawa. Dr. Labib will represent the 10 authors and discuss the “statistically significant” improvement in patients’ neurological state associated with early intervention of hematoma.

Dr. Labib is also a member of the newly formed Subcortical Surgery Group, a growing team of neurosurgeons using new technologies to enable access to deep parts of the brain while preserving essential tissue and structures. In this 10-center study, the BrainPath technology was used as a means of standardizing access to the emergent brain abnormality for early evacuation.

WHAT: International Stroke Conference podium presentation: “The Safety and Efficacy of Image Guided Trans-Sulcal Radial Corridors for Hematoma Evacuation: A Multi-Center Study”
WHO: Dr. Mohamed Labib, University of Ottawa
DATE: Thursday, February 12th, 2015
TIME: 1:30-3:00p.m. EST (estimated presentation time between 2:10-2:40 p.m.)
WHERE: Music City Center, 201 5th Ave. S, Nashville, Tennessee

Dr. Labib’s presentation will be available to the public following the presentation. For more information, please contact: media@brainpath.com

For more information on the ISC: http://my.americanheart.org/professional/Sessions/InternationalStrokeConference/International-Stroke Conference_UCM_316901_SubHomePage.jsp

For more information on the Subcortical Surgery Group, please contact: info@subcorticalsurgery.com or visit www.subcorticalsurgery.com

About the BrainPath Technology:
The patented BrainPath provides unique atraumatic surgical access to brain abnormalities. It is uniquely designed to minimize tissue damage by displacing tissues of the brain during advancement to the abnormality – much like the way a boat hull moves through water by displacing what is in front of it – all through an opening smaller than a dime. The outer sheath remains in the brain to serve as a protective portal for surgeons to easily maintain access to the surgical site during tissue removal or fluid evacuation.

Uncategorized

Footer

OUR MISSION is SIMPLE

We provide proven and patented technologies that integrate imaging and intervention for a safe, minimally disruptive approach to brain surgery. This integration drives efficiencies for the patient, surgeon and healthcare provider.

Customer Service

 Tel: (317) 660-7118
 Email Us

Follow NICO Here

  • LinkedIn
  • Twitter
  • YouTube
Social Media Links

Search Our Website

privacy policy   ·    terms of use   ·    patents    ·   labeling

Copyright © 2023 · Nico Corporation · NICO Myriad and BrainPath are “tools” not “treatments”. Physicians should use their best judgment and clinical experience when deciding how to use the Myriad and BrainPath. The latest information, including contraindications, warnings and precautions can be obtained by consulting product labeling or your local NICO representative.